Roger Collier. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisDrug Costs/legislation & jurisprudenceDrug Therapy/economicsHumansLegislation, Drug/economicsUnited Kingdom
Year: 2010 PMID: 20974726 PMCID: PMC2988556 DOI: 10.1503/cmaj.109-3694
Source DB: PubMed Journal: CMAJ ISSN: 0820-3946 Impact factor: 8.262